Around 20 million Americans reportedly trust this medication—here are the recall details, and the unusual error that caused ...

However, metformin did not protect Black patients against squamous cell carcinoma specifically. “This study strengthens the evidence supporting metformin's potential as a protective agent ...

These three NDAs of Sitagliptin (base) and combination franchise had been approved by the USFDA earlier. (Image Credits: Pixabay) Zydus Lifesciences Ltd on Tuesday announced that it has entered ...

(Dapagliflozin propanediol + metformin hydrochloride) ER is under clinical development by Yooyoung Pharm and currently in Phase III for Type 2 Diabetes. According to GlobalData, Phase III drugs for ...

A Side Note on Metformin Safety Recalls Many manufacturers of metformin hydrochloride have recalled their medications because of potentially high levels of an ingredient found to cause cancer.

While shares of Tech Mahindra, TCS, Persistent Systems, Infosys, Mphasis, HCL Tech, LTIMindtree and Coforge are down by 1% to 2%. The bearish tone in IT stocks comes ahead of Q3 results season.

Can a low-cost diabetes medication help improve survival for overweight and obese individuals with lung cancer? New research suggests that metformin, a drug commonly used to manage blood glucose ...